Sellas Life Valuation
| SLS Stock | USD 1.06 0.08 8.16% |
Today, the company appears to be undervalued. Sellas Life Sciences has a current Real Value of $2.25 per share. The regular price of the company is $1.06. Our model measures the value of Sellas Life Sciences from inspecting the company fundamentals such as Return On Equity of -8.88, shares outstanding of 70.38 M, and Shares Owned By Institutions of 7.36 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Sellas Life's valuation include:
Price Book 4.3526 | Enterprise Value | Enterprise Value Ebitda (1.71) | Price Sales 26.8951 | Enterprise Value Revenue 20.8445 |
Undervalued
Today
Please note that Sellas Life's price fluctuation is very risky at this time. Calculation of the real value of Sellas Life Sciences is based on 3 months time horizon. Increasing Sellas Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sellas stock is determined by what a typical buyer is willing to pay for full or partial control of Sellas Life Sciences. Since Sellas Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sellas Stock. However, Sellas Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.06 | Real 2.25 | Target 5.83 | Hype 1.06 |
The intrinsic value of Sellas Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sellas Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sellas Life Sciences helps investors to forecast how Sellas stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sellas Life more accurately as focusing exclusively on Sellas Life's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Sellas Life's intrinsic value based on its ongoing forecasts of Sellas Life's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Sellas Life's closest peers.
Sellas Life Cash |
|
Sellas Valuation Trend
Sellas Life's real value is important for investors to make better decisions and a more accurate overall view of Sellas Life's financial worth over time. Using both Sellas Life's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Sellas Life Total Value Analysis
Sellas Life Sciences is at this time expected to have company total value of 48.72 M with market capitalization of 74.6 M, debt of 906 K, and cash on hands of 26.99 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Sellas Life fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
48.72 M | 74.6 M | 906 K | 26.99 M |
Sellas Life Asset Utilization
One of the ways to look at asset utilization of Sellas is to check how much profit was generated for every dollar of assets it reports. Sellas Life Sciences has a negative utilization of assets of -1.29 %, losing $0.0129 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Sellas Life Sciences shows how discouraging it operates for each dollar spent on its assets.Sellas Life Ownership Allocation
Sellas Life Sciences shows a total of 70.38 Million outstanding shares. About 92.4 % of Sellas Life outstanding shares are held by general public with 0.24 (%) owned by insiders and only 7.36 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sellas Life Profitability Analysis
Reported Net Loss for the year was (37.34 M) with profit before taxes, overhead, and interest of 900 K.About Sellas Life Valuation
The stock valuation mechanism determines Sellas Life's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Sellas Life Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sellas Life. We calculate exposure to Sellas Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sellas Life's related companies.| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (47.50) | (45.12) | |
| Operating Profit Margin | (48.24) | (45.83) | |
| Net Loss | (46.75) | (44.41) | |
| Gross Profit Margin | 0.81 | 0.70 |
Sellas Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Sellas Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 27.8 M |
Sellas Life Current Valuation Indicators
Sellas Life's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Sellas Life's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Sellas Life, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Sellas Life's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Sellas Life's worth.Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.